Skip to main content
OpenTrials

Clinical trial condition

Neuroblastoma

Explore clinical trials studying Neuroblastoma. Study availability and eligibility vary by location and protocol.

492 public trials 88 recruiting studies
Refine in advanced search Browse all conditions

Neuroblastoma trial results

Recruiting

Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

NCT05489887

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • University of Alabama/Children's of Alabama Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
  • Rady Children's Hospital San Diego, California, United States
View all 26 locations
View Trial Details
Recruiting

SPEARHEAD-3 Pediatric Study

NCT05642455

Conditions
Fibrosarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Neoplasms, +26 more
Locations
  • Stanford University Palo Alto, California, United States
  • National Institutes of Health Bethesda, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University St Louis, Missouri, United States
View Trial Details
Recruiting

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

NCT06057948

Conditions
High-risk Neuroblastoma, Metastatic Neuroblastoma, Neoplasms, +9 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Consent only) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent Only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent Only) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Consent only) Commack, New York, United States
View Trial Details
Recruiting

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

NCT06721689

Conditions
Disease Attributes, Myosarcoma, Neoplasms, +22 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

NCT06450041

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • UCSF Benioff Children's Hospital San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Comer Children's Hospital, University of Chicago Chicago, Illinois, United States
View all 13 locations
View Trial Details
Recruiting

Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation

NCT06942039

Conditions
Atypical Teratoid Rhabdoid Tumor, Brain Diseases, Brain Neoplasms, +38 more
Locations
  • Alberta Children's Hospital Calgary, Alberta, Canada
  • BC Children's Hospital Vancouver, British Columbia, Canada
  • CancerCare Manitoba (CCMB) Winnipeg, Manitoba, Canada
  • IWK Health Centre Halifax, Nova Scotia, Canada
View Trial Details

Related conditions